TABLE 3.

Treatment-Related Adverse Events

Event	Total, No. (%)	Grade 1, No. (%)	Grade 2, No. (%)	Grade 3, No. (%)
Pruritus	10 (13.7)	5 (6.8)	5 (6.8)	—
Rash	9 (12.3)	5 (6.8)	3 (4.1)	1 (1.4)
Nail disorder	8 (11.0)	3 (4.1)	5 (6.8)	—
Paronychia	7 (9.6)	2 (2.7)	5 (6.8)	—
Diarrhea	5 (6.8)	5 (6.8)	—	—
Nausea	5 (6.8)	4 (5.5)	1 (1.4)	—
Mucositis	4 (5.5)	2 (2.7)	2 (2.7)	—
Decreased appetite	4 (5.5)	3 (4.1)	1 (1.4)	—
Headache	3 (4.1)	—	3 (4.1)	—
Dry skin	3 (4.1)	3 (4.1)	—	—
Insomnia	2 (2.7)	—	2 (2.7)	—
Stomatitis	2 (2.7)	2 (2.7)	—	—
Vomiting	2 (2.7)	1 (1.4)	1 (1.4)	—
Alanine aminotransferase increased	2 (2.7)	2 (2.7)	—	—
Dizziness	2 (2.7)	1 (1.4)	1 (1.4)	—
Muscle weakness	1 (1.4)	—	1 (1.4)	—
Dysphagia	1 (1.4)	1 (1.4)	—	—
Cardiac failure	1 (1.4)	—	—	1 (1.4)
Confusional state	1 (1.4)	—	—	1 (1.4)
Neutropenia	1 (1.4)	—	—	1 (1.4)